Increased tumor necrosis factor-α, cleaved caspase 3 levels and insulin receptor substrate-1 phosphorylation in the

Surekha Rani Panjala1, Youde Jiang, Timothy S Kern

  • 1Department of Ophthalmology, Hamilton Eye Institute, The University of Tennessee Health Science Center, Memphis, TN, USA.

Molecular Vision
|August 19, 2011
PubMed
Abstract

Insights

Loss of beta1-adrenergic receptors in mice increased retinal vascular degeneration and apoptosis. This suggests beta-adrenergic receptor signaling is crucial for maintaining retinal health and may offer therapeutic targets for retinal diseases.

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Molecular Biology

Background:

  • Beta-adrenergic receptors play roles in various physiological processes.
  • Insulin-like growth factor-1 (IGF-1) receptor signaling is vital for cell growth and survival.
  • Retinal homeostasis is critical for vision, and its disruption is implicated in diseases like diabetic retinopathy.

Purpose of the Study:

  • To investigate the impact of beta1-adrenergic receptor deficiency on IGF-1 receptor signaling and apoptosis in the retina.
  • To utilize beta1-adrenergic receptor knockout (KO) mice to model the effects of receptor loss.

Main Methods:

  • Western blotting and ELISA were used to analyze retinal lysates from beta1-adrenergic receptor KO and wild-type mice.
  • Vascular degeneration, including degenerate capillaries and pericyte ghosts, was assessed.
  • Levels of cleaved caspase 3, tumor necrosis factor alpha, IGF-1 receptor phosphorylation, Akt phosphorylation, and IRS-1(Ser307) phosphorylation were measured.

Main Results:

  • Beta1-adrenergic receptor knockout led to increased degenerate capillaries and pericyte ghosts in the retina.
  • Cleaved caspase 3 and tumor necrosis factor alpha levels were elevated in KO mice.
  • While IGF-1 receptor phosphorylation remained unchanged, Akt phosphorylation was significantly decreased, likely due to increased inhibitory IRS-1(Ser307) phosphorylation.

Conclusions:

  • Beta-adrenergic receptor signaling is essential for maintaining retinal homeostasis.
  • Loss of beta1-adrenergic receptors disrupts retinal TNF-alpha and apoptosis levels and alters key signaling pathways (Akt, IGF-1R).
  • These findings suggest that beta-adrenergic receptor modulators could be potential therapeutic agents for retinal conditions, particularly diabetic retinopathy.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...